GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKIN.L Share News (SKIN)

  • There is currently no data for SKIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Integumen upbeat on promising cannabis skincare test results

Mon, 25th Mar 2019 11:39

(Sharecast News) - Integumen announced positive results from further tests in formulations on Monday, all of which contained low-concentrations of hemp-derived cannabinoid (CBD) oils.The AIM-traded firm said the formulations increased production of pro-collagen, and indicated a reduction of inflammation on 'Labskin', leading to a soothing effect on irritated and sore skin.It explained that pro-collagen had been shown to improve the "youthfulness" of skin appearance, and was a precursor of collagen - the protein that adds strength and support to body tissue.The amount of pro-collagen production could be directly measured, as no additional collagen was added to the Labskin model.Inflammation, meanwhile, could be caused by a variety of reasons ranging from bacterial infection to irritation from harsh skin products, Integumen explained.It said Labskin was capable of releasing chemical markers that indicated inflammation damage occurring on the skin test model.The trial data showed that formulations containing hemp-derived CBD oil, in low concentrations, reduced the release of those inflammation markers, indicating a soothing effect on sore skin.Ingegume's updates on 7 January and 20 February noted that Cellulac, which is 9.35% owned by Integumen, had developed a low-cost hemp-derived CBD oil extraction process and was collaborating with Labskin to provide a formulation for the 'STOER For Men' range of cosmetics."Scientific evidence to back up anti-ageing or problematic skin treatments is far superior to anecdotal percentages of product testers," said Integumen chief executive officer Gerard Brandon."With no animal testing allowed, consumers still have a right to know what the real impact and effect of products have on their skin, before they use it."Further tests and product approvals were still required before consideration of launching an extension to the range of STOER For Men skin care products, Brandon explained."Labskin is now offering the same test services to clients adding CBD to their skin-care and cosmetic range of products."
More News
19 Dec 2019 12:25

Integumen To Supply Rinocloud Data Storage Software To Parity Clients

Integumen To Supply Rinocloud Data Storage Software To Parity Clients

Read more
9 Dec 2019 14:56

Integumen To Raise GBP1.4 Million To Double Labskin Laboratory Size

Integumen To Raise GBP1.4 Million To Double Labskin Laboratory Size

Read more
9 Dec 2019 08:45

Integumen raises ?1.36m via subscription and placing

(Sharecast News) - Life sciences company Integumen raised approximately £1.36m via a subscription and placing on Monday in order to maintain its current pace of growth.

Read more
20 Nov 2019 14:41

Integumen Says AI Water Research Project Delivers Successful Results

Integumen Says AI Water Research Project Delivers Successful Results

Read more
13 Nov 2019 12:14

Integumen Agrees To Deliver Data Solutions Across Parity Clients

Integumen Agrees To Deliver Data Solutions Across Parity Clients

Read more
13 Nov 2019 10:27

Integumen and Parity reach multi-year AI deal

(Sharecast News) - Integumen has signed heads of terms with Parity to enter a multi-year framework agreement to be completed on or before 18 December, it announced on Wednesday, for the supply of artificial intelligent (AI) software across Parity's NHS, central government and private institutional clients.

Read more
7 Nov 2019 15:56

Integumen signs three new agreements for Labskin

(Sharecast News) - Integumen announced on Thursday that its Labskin subsidiary has signed agreements with two new, and one existing, top 20 global cosmetic company clients for microbiome research and development services.

Read more
7 Nov 2019 13:28

Integumen Secures Research & Development Contracts With Three Firms

Integumen Secures Research & Development Contracts With Three Firms

Read more
29 Oct 2019 12:16

Integumen launches 'Rinodrive' artificial intelligence platform

(Sharecast News) - Integumen announced the launch of 'Rinodrive' as an independent artificial intelligence (AI) platform for collaboration and joint venture partners on Tuesday, as an open-source cloud-based ecosystem.

Read more
7 Oct 2019 15:16

Integumen signs two new multi-year agreements

(Sharecast News) - Integumen has signed multi-year agreements with two unnamed 'top 10' global cosmetic companies for recurring LabskinAI services, it announced on Monday, with initial aggregate low six-figure payments already received.

Read more
7 Oct 2019 11:37

Integumen Signs Service Agreements, Completes Psoriasis Skin Model

Integumen Signs Service Agreements, Completes Psoriasis Skin Model

Read more
11 Sep 2019 10:43

Integumen Interim Revenue Rises But Losses Widen On Higher Expenses

(Alliance News) - Shares in skincare firm Integumen PLC fell on Wednesday as it reported a widened first half loss despite recently-acquired Rinocloud Ltd boosting revenue.Shares in the at

Read more
2 Aug 2019 12:40

Highlands Natural Resources Inks CBD Supply Agreement With Cellulac

(Alliance News) - Highlands Natural Resources PLC on Friday said it has signed a two-year cannabidiol supply deal with Cellulac PLC.Shares in Highlands were up 12% at 7.52 pence in mid day

Read more
31 Jul 2019 13:55

Integumen Demand Continues To Be "Significantly" Ahead Of Past Levels

(Alliance News) - Integumen PLC said Wednesday the current level of pipeline activity is "significantly higher than the company has experienced in the past".As a result, the firm

Read more
29 Jul 2019 12:39

Integumen Expands Wound Care Division Through Cellulac CBD Agreement

(Alliance News) - Integumen PLC on Monday said it is expanding its Wound pHase wound care division to include cannabidiol-infused wound dressings by extending its licence technology agreement with

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.